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Despite the high 企equency of prostate cancer (PCA), therapeutic options for advanced disease are limited to 
chemotherapy, radiation or hormonal therapy, and eventually fail in al patients ; therefore alternative 
approaches need to be developed. We previously reported that FTY720, a metabolite 仕om Isaria sinclarii, is a 
unique antitumor agent for an androgen-independent prostate cancer cellline, and required caspase-3 activation 
in a dose-related apoptosis. But the cellular mechanisms of the action of FTY720 on cancer cells are not 
completely understood. In this study, we have evaluated the effect ofFTY720 on a family ofmitogen-activated 
protein kinases (MAPKs) , focal adhesion kinase (FAK) , mitochondrial transmembrane potential, caspase-g, 
caspase-8 and analyzed the expression of some cell-cycle regulator proteins in DU145 cells in order to 
understand the various antitumor effects of FTY720. 
Method 
1) Apoptosis was quantified by phosphatidylserine exposure, determined by Annexin VIFITC apoptosis 
detection kit and FACS analysis coupled with propidium iodide staining to exclude necrotic cells. 
2) Activation of MAPKs (SAPKlJNK, p38 MAPK, ERK1I2 and the upper stream kinase MKK3IMKK6), 
cleavage of caspase-g and caspase-8, status of cyclin-dependent kinases (CDKs) and Cipl/p21, a 
cyclin-dependent kinase inhibitor were evaluated by Western blot analyses, in addition to FAK and 
phospho・FAK immunoprecipitation. 
3) Mitochondrial transmembrane potential and cell-cycle analysis by FACScan. 
民U? ?
Results 
1) 40μM of FTY720 induced time-dependent apoptosis together with processing of the caspase-9 and 
caspase-8 as well as lowering the depolarization of the mitochrondrial membrane potential in DU145 cels. 
2) p38 MAPK and MKK3瓜tfKK6were activated during FTY720・induced apoptosis, But not SAPKlJNK. 
3) FTY720 decreased ERK1I2 phosphorylation in a time-dependent manne1', as well as reduced FAK protein 
expression, and completely blocked the activation of F AK. 
4) The b1'oad-spectrum caspase inhibitor z-VAD.FMK (20μM) but not p38古lhibitor SB203580 (10μM) 
blocked apoptosis in DU145 cells by FTY720. 
5) z-VAD.FMK (20・ 100μM) did not block p38 MAPK activation in 1'esponse to FTY720 
6) FTY720 (40 and 20μM) resulted in a significant down-1'egulation of CDK2 and CDK4 p1'otein levels in 24 
hou1's whereas it induced Cip lIp21 
7) F ACS analysis of controls and FTY720・t1'eated DU145 cells indicated that a 01 arrest was induced by 20μ 
M FTY720 following 24 h of treatment. The increase in the G1 population was accompanied by a decrease 
in cells in the S phase, whereas the 02・Mpopulation was essentially unchanged. 
Conclusion 
1) FTY720 induced involvement of caspase-8 as well as caspase-9 and decreased depolarization of the 
mitochondrial membrane potential suggested that the mitochondrial death pathway mediated apoptosis in 
the DU145 cellline. 
2) 40μM FTY720 caused activation ofp38 MAPK and the upstream kinase MKK3瓜tIKK6， but not SAPKlJNK. 
The mechanism ofp38 MAPK activation is a stimulus-dependent and caspase-independent pathway. 
3) The contribution ofFAK to MAPK pathways occurred in DU145 cells, because both FAK and ERK1/2 were 
decreased by FTY720. 
4) The regulators of the cell cycle are potential epigenetic targets and induction of 01 arrest fo1' p1'ostate cancer 
treatment by FTY720. • 
5) FTY720 may exert anticarcinogenic e首ects agaii1st prostate cancer cells possibly involving nodulation of 
mitogenic signaling, cell-cycle regulators, induction of 01 ar1'est and apoptotic 
論文審査の結果の要旨
FTY720 は新しい免疫抑制剤であり、免疫抑制作用以外に抗腫療効果も持っていることが判明している。本研究は
ヒト前立腺癌細胞株 DU-145 に対する FTY720 の細胞増殖抑制作用の機構を解明する目的でなされたものである。
具体的には細胞増殖抑制効果をアポトーシスと細胞周期の両面から検討した。アポトーシスでは、ミトコンドリア
の細胞膜電位の低下から caspase-8 、 9、さらに caspase-3 の経路が存在することを証明した。また、 FTY720 による
DU145 細胞のアポトーシス過程において、 p38 MAPK と MKK3瓜tIKK6 が活性化されることを示した。 ERK1/2 は
通常 DU145 に多量に発現しているが、 FAK 活性と ERK1I2 のリン酸化の減少とが認められ、 FAK 活性の阻害で
ERK1I2 の減少が抑制されることを示した。細胞周期については、 FTY720 処理を行うことによって 01 arrest を生
じていることを示し、この理由として CDK2 、 4 の発現増加とその抑制作用を持つ Cip lIp21 の増加を明らかにした。
本研究は、 FTY720 の DU145 細胞に対する増殖抑制効果の機構に関して、アポトーシスの経路を明らかにし、細
胞周期の変動も関与すると言う新しい知見を提供した。また、抗腫蕩効果をも併せ持つ FTY720 が免疫抑制剤として
のみならず、悪性腫療を発症しやすい移植患者において腫蕩発生率を下降させる臨床的意義の可能性を示している。
以上のことより、本研究は学位の授与に値すると考えられる。
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